NCT00678691View on ClinicalTrials.gov

An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions
Fibromyalgia, Primary
Interventions
DRUG

armodafinil

50-250mg/d

DRUG

placebo

matching placebo

Trial Locations (1)

13210

SUNY Upstate Medical University, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT00678691 - An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue | Biotech Hunter | Biotech Hunter